References
Adamantiades B: Sur un cas d'iritis a hypopyon recidivant. Oculist 138:271-278, 1931
Behcet H: über rezidivierende, aphtöse Geschwüre im Mund, Auge und an den Genitalien. Dtsch Med Wochenschr 105:1152-1157, 1937
Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 341:1284-1291, 1999
International Study Group for Behcet's Disease: Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080, 1990
Duhrsen U, Kirch W: Diagnosis of Behcet's syndrome. Dtsch Med Wochenschr 110:264-267, 1985 (in German)
Zouboulis CC: Epidemiology of Adamantiades-Behcet's disease. Ann Med Intern (Paris) 150:488-498, 1999
Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Sohnchen R, Weber H, Gollnick HP, Holzle E, Fritz K, Licht T, Orfanos CE: Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 38:411-422, 1997
Mizuki N, Inoko H, Ohno S: Pathogenic gene responsible for the predisposition of Behcet's disease. Int Rev Immunol 14:33-48, 1997
Tabata M, Tomomasa T, Kaneko H, Morikawa A: Intestinal Behcet's disease: a case report and review of Japanese reports in children. J Pediatr Gastroenterol Nutr 29:477-481, 1999
Lehmann H, Stutte HJ, Zierott G, Schlaak M: A case of Behcet's disease with multiple intestinal ulcerations Dtsch Med Wochenschr 100:308-311, 1975 (in German author's transl)
Arma S, Habibulla KS, Price JJ, Collis JL: Dysphagia in Behcet's syndrome. Thorax 26:155-158, 1971
Mori S, Yoshihira A, Kawamura H, Takeuchi A, Hashimoto T, Inaba G. Esophageal involvement in Behcet's disease. Am J Gastroenterol 78:548-553, 1983
Yashiro K, Nagasako K, Hasegawa K, Maruyama M, Suzuki S, Obata H: Esophageal lesions in intestinal Behcet's disease. Endoscopy 18:57-60, 1986
Ikezawa K, Kashimura H, Hassan M, Nakahara A, Yanaka A, Matsuzaki Y, et al: A case of Behcet's syndrome with esophageal involvement treated with salicylazosulfapyridine and prednisolone. Endoscopy 30:S52-S53, 1998
Lorenzetti ME, Forbes IJ, Roberts-Thomson IC: Oesophageal and ileal ulceration in Behcet's disease. J Gastroenterol Hepatol 5:714-717, 1990
Glosemeyer R, Deppe H, Dormann AJ, Wigginghaus B, Stolte M, Stadler R, et al: Ulcerative esophagitis and colitis as rare manifestations of Adamantiades-Behcet disease. Z Gastroenterol 39:167-171, 2001 (in German)
Reimer G, Luckner L, Hornstein OP: Direct immunofluorescence in recurrent aphthous ulcers and Behcet's disease. Dermatologica 167:293-298, 1983
Savage NW, Mahanonda R, Seymour GJ, Bryson GJ, Collins RJ: The proportion of suppressor-inducer T-lymphocytes is reduced in recurrent aphthous stomatitis. J Oral Pathol 17:293-297, 1988
Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T: Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behcet's disease. Rheumatol Int 19:23-26, 1999
Hamza M, Makni S: Secretory component deficiency in Behcet's disease. Clin Rheumatol 14:227-228, 1995
Emmi L, Brugnolo F, Salvati G, Marchione T: Immunopathological aspects of Behcet's disease. Clin Exp Rheumatol 13:687-691, 1995
Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544-1549, 1993
Freitas JP, Filipe P, Yousefi A, Emerit I, Guerra RF: Oxidative stress in Adamantiades-Behcet's disease. Dermatology 197:343-348, 1998
Hamzaoui K, Hamza M, Ayed K: Production of TNF-alpha and IL-1 in active Behcet's disease. J Rheumatol 17:1428-1429, 1990
Freysdottir J, Lau S, Fortune F: Gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451-457, 1999
Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T: Role of gammadelta T lymphocytes in the development of Behcet's disease. Clin Exp Immunol 107:241-247, 1997
Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C: The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 163:2314-2321, 1999
Hamza M, Elleuch M, Slim A, Hamzaoui K, Ayed K: Antibodies to herpes simplex virus in patients with Behcet's disease. Clin Rheumatol 9:498-500, 1990
Sohn S, Lee ES, Bang D, Lee S: Behcet's disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur J Dermatol 8:21-23, 1998
Hamzaoui K, Kahan A, Ayed K, Hamza M: Cytotoxic T cells against herpes simplex virus in Behcet's disease. Clin Exp Immunol 81:390-395, 1990
Lehner T: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int Rev Immunol 14:21-32, 1997
Namba K, Ueno T, Matsumi F, Okita M, Yumita A, Fujino Y, Fujie W: Behcet's disease and Streptococcus infection. Time course of titer of streptococcal antigen and comparison with other uveitis. Nippon Ganka Gakkai Zasshi 89:200-207, 1985 (in Japanese)
Isogai E, Ohno S, Kotake S, Isogai H, Tsurumizu T, Fujii N, Yokota K, Syuto B, Yamaguchi M, Matsuda H: Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 35:43-48, 1990
Zouboulis CC, Orfanos CE: Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 134:1010-1016, 1998
Hamuryudan V, Moral F, Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Direskeneli H, Akoglu T, Yazici H: Systemic interferon alpha 2b treatment in Behcet's syndrome. J Rheumatol 21:1098-1100, 1994
Sakane T, Takene M: Interferon therapy in Behcet's disease. Intern Med 39:604-605, 2000
Kotter I, Durk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M: Therapy of Behcet's disease. Ger J Ophthalmol 5:92-97, 1996
Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE: A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 322:281-285, 1990
Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, Senocak M, Yazici H: Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 40:769-774, 1997
Ozyazgan Y, Yurdakul S, Yazici H, Tuzun B, Iscimen A, Tuzun Y, Aktunc T, Pazarli H, Hamuryudan V, Muftuoglu A: Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial. Br J Ophthalmol 76:241-243, 1992
Diaz-Llopis M, Cervera M, Menezo JL: Cyclosporin A treatment of Behcet's disease: a longterm study. Curr Eye Res 9(supp):17-23, 1990
Park JY, Park JG, Won JH, Lee JM, Kim NS, Jung TH: Effects of corticosteroid and chlorambucil on multiple pulmonary artery aneurysms in Behcet's syndrome. A case report. J Korean Med Sci 10:470-473, 1995
Simsek I, Dinc A, Mas MR, Gunhan O, Kocabalkan F: Behcet's disease with a cecal perforation. Clin Exp Rheumatol 18:268-269, 2000
Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H: A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum 44:2686-2692, 2001
Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H: Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443-450, 1998
Ranselaar CG, Boone RM, Kluin-Nelemans, HC: Thalidomide in the treatment of neuro-Behcet's syndrome. Br J Dermatol 115:367-370, 1986
Hamza M, Hamzaoui K, Ayed K: Treatment of Behcet's disease with dapsone. Clin Rheumatol 8:113-114, 1989
Hisamatsu T, Kishikawa H, Fukuya H, Matsuoka K, Mizuno Y, Nishida J: Combination therapy including pentoxifylline for entero-Behcet's disease. Bull Tokyo Dent Coll 42:169-176, 2001
Hamuryudan V, Ozyazgan Y, Yazici H: Treatment of Bechet disease with pentoxifylline. Ann Intern Med 126:493, 1997
Sonta T, Araki Y, Koubokawa M, Tamura Y, Ochiai T, Harada N, Chijiiwa Y, Nawata H: The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet's disease. J Clin Gastroenterol 30:195-199, 2000
Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WJ, Chi HS: Surgical treatment of intestinal Behcet's disease. Yonsei Med J 38:455-460, 1997
Sakane T, Takeno M: Novel approaches to Behcet's disease. Expert Opin Investig Drugs 9:1993-2005, 2000
Hassard PV, Binder SW, Nelson V, Vasiliauskas EA: Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report. Gastroenterology 120:995-999, 2001
Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL: Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49:725-728, 2001
Rights and permissions
About this article
Cite this article
Wedemeyer, H., Kuipers, J.G., Streetz, K. et al. CASE REPORT: A Rare Manifestation of Behçet's Syndrome: Immunological Correlates and Successful Treatment of an Esophageal Ulcer. Dig Dis Sci 48, 1385–1391 (2003). https://doi.org/10.1023/A:1024183931726
Issue Date:
DOI: https://doi.org/10.1023/A:1024183931726